Vivian Y. Shi

High Impact

Researcher

UAMS primary UA Little Rock

Also affiliated: Boston University (2024); Northwestern University (2024); University of Southern California (2022); Centers for Disease Control and Prevention (2021); Apple (Israel) (2021); Harvard University (2023); University of Arizona (2016–2022); University of Illinois Urbana-Champaign (2011–2017); University of California, Los Angeles (2007–2022); Illinois College (2011–2017); University of California, San Francisco (2021); Providence College (2025); University of Washington (2024–2025); Loma Linda University (2015); University of Arkansas Medical Center (2020–2023); University of Alabama at Birmingham (2024); University of Illinois Chicago (2011–2017); Arkansas Cardiology (2020); Hasbro Children's Hospital (2025); Zero to Three (2022); Creative Commons (2021–2022); Banner - University Medical Center Tucson (2017–2020); Hospital of the Brothers of St. John of God (2009); Institute for Conflict Research (2021); Olive View-UCLA Medical Center (2020); Stanford Medicine (2023); Community Connections (2022); Vince Lombardi Cancer Clinic (2018); Eagle Mount (2021); Bayer (China) (2017); Jacobs Institute (2022); Jacobs (United States) (2022); University of California Davis Medical Center (2016); Arkansas Department of Agriculture (2020–2024); Tris Pharma (United States) (2021); Lebanese American University (2019); Seattle University (2024–2025); University at Buffalo, State University of New York (2022); Columbia University (2020–2021); University of California, Davis (2013–2016); Stanford University (2021–2024)

Faculty Researcher

40 h-index 408 pubs 5,472 cited

Research Areas

Biomedical Subjects

Links

ORCID Research Group

OverviewAI-generated summary

Vivian Y. Shi's research focuses on dermatological conditions, particularly atopic dermatitis and hidradenitis suppurativa. She has investigated the efficacy and safety of pharmacological interventions for moderate-to-severe atopic dermatitis, including studies on abrocitinib and delgocitinib. Her work also extends to understanding the role of Staphylococcus aureus in atopic dermatitis and exploring new approaches to skin barrier function and moisturization.

Shi has also contributed to the literature on hidradenitis suppurativa through systematic reviews and meta-analyses of treatments such as infliximab. Her broader research interests include advancements in point-of-care diagnostics, particularly in the context of infectious disease outbreaks. She leads a research group and has a significant publication record, with 408 total publications and an h-index of 40, indicating substantial scholarly impact.

Her collaborations include work with fellow researchers at the University of Arkansas for Medical Sciences, such as Charlotte Y. Jeong, Jay Kincannon, Edita M. Newton, and Henry Bishop.

Metrics

h-index: 40
Publications: 408
Citations: 5,472

Selected Publications

Real-world evidence on the benefits of optimal itch relief and skin clearance in atopic dermatitis management: a study from the TARGET-DERM AD registry (2024)

Journal of Dermatological Treatment 6 citations DOI OpenAlex
Readability of Information Generated by ChatGPT for Hidradenitis Suppurativa (2024)

JMIR Dermatology 6 citations DOI OpenAlex
Ustekinumab in Hidradenitis Suppurativa: A Systematic Review and Meta-analysis (2024)

Dermatology and Therapy 8 citations DOI OpenAlex
Adherence to Hidradenitis Suppurativa Treatment (2024)

American Journal of Clinical Dermatology 5 citations DOI OpenAlex
Spironolactone in hidradenitis suppurativa: a single-center (2024)

International Journal of Women’s Dermatology 8 citations DOI OpenAlex
Expert Practices in Hidradenitis Suppurativa Flare Management: A Cross-Sectional Survey Study (2024)

Skin Appendage Disorders 10 citations DOI OpenAlex
Impact of Crisaborole in Treatment-Experienced Patients with Mild-to-Moderate Atopic Dermatitis (2024)

Dermatitis 6 citations DOI OpenAlex
No-Shows to Hidradenitis Suppurativa Clinic Visits: Patient Perspectives (2023)

Skin Health and Disease 6 citations DOI OpenAlex
Top cited articles in dissecting cellulitis of the scalp: A bibliometric analysis (2023)

Skin Research and Technology 6 citations DOI OpenAlex
Treatments for Dissecting Cellulitis of the Scalp: A Systematic Review and Treatment Algorithm (2023)

Dermatology and Therapy 29 citations DOI OpenAlex
The Skin Barrier and Moisturization: Function, Disruption, and Mechanisms of Repair (2023)

Skin Pharmacology and Physiology 164 citations DOI OpenAlex
Managing seasonal flares in hidradenitis suppurativa (2023)

Journal of the American Academy of Dermatology 6 citations DOI OpenAlex
Efficacy of medical treatments for pediatric hidradenitis suppurativa: A systematic review (2023)

Pediatric Dermatology 17 citations DOI OpenAlex
Racial and Ethnic Differences in Sociodemographic, Clinical, and Treatment Characteristics Among Patients with Atopic Dermatitis in the United States and Canada: Real-World Data from the CorEvitas Atopic Dermatitis Registry (2023)

Dermatology and Therapy 11 citations DOI OpenAlex
Emerging Treatments and the Clinical Trial Landscape for Hidradenitis Suppurativa—Part II: Procedural and Wound Care Therapies (2023)

Dermatology and Therapy 7 citations DOI OpenAlex